Study to Evaluate the Safety and Tolerability of PRO-231 Versus VIGAMOXI® on the Ocular Surface of Healthy Subjects
Clinical trial NCT06363292 · COMPLETED
Trial details
- NCT number
- NCT06363292
- Sponsor
- Laboratorios Sophia S.A de C.V.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-30
- Primary completion
- 2024-05-28
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.